Vanguard Fiduciary Trust »

Gain Therapeutics shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $446k 230k 1.94

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
Susquehanna International
Jones Financial Companies, L.L
Vanguard Group
Cambridge Investment Research Advisors
DME Capital Management
Geode Capital Management
Vanguard Capital Management
GSA Capital Partners
Jane Street
Vanguard Fiduciary Trust
BlackRock
UBS Group
Cresset Asset Management

View all funds holding Gain Therapeutics